Thermo Fisher Scientific TMO
NYSE TMO
$719.26 +1.06 (+0.15%)
As of: Nov 11, 2026 · 9:54 AM EST

Thermo Fisher Scientific (TMO) Non-Current Deferred Revenue (2017 - 2019)

Updated

Analysis

Thermo Fisher Scientific (TMO) Non-Current Deferred Revenue (2017 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Agilent Technologies 50.15 Bn 43.04 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 594.00 Mn
Dec 31, 2018 355.00 Mn
Sep 29, 2018 349.00 Mn
Jun 30, 2018 337.00 Mn
Mar 31, 2018 317.00 Mn
Dec 31, 2017 322.00 Mn
API Access

Thermo Fisher Scientific Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TMO&period=max&api_key=YOUR_API_KEY